Age: 66.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Myalgia, Pyrexia
Clinical narrative: Rigors; shaking chills; muscle aches; headache; fatigue; fever to 103.4; Dose: 3rd; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 29Oct2021 12:30 (Lot number: FF2581) at the age of 66 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine inact split 4v (FLUZONE HIGH DOSE QUADRIVALENT), intramuscular, administered in arm right, administration date 29Oct2021 (Batch/Lot number: unknown) as dose 1, single for immunisation. Relevant medical history included: "High cholesterol" (ongoing); "low vit D/ decreased vit D" (ongoing); "Difficulty sleeping/ insomnia" (ongoing). Concomitant medication(s) included: CRESTOR; VITAMIN D taken for vitamin d decreased, start date: Jan2020 (ongoing); ADVIL PM; XYZAL; ROSUVASTATIN taken for blood cholesterol increased (ongoing); TYLENOL PM taken for insomnia (ongoing). Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8738, Anatomical site of injection: Arm, Route of administration: Intramuscular), administration date: 05Apr2021, when the patient was 66 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0172, Anatomical site of injection: Arm), administration date: 27Apr2021, when the patient was 66 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 29Oct2021 12:30, outcome "unknown", described as "Dose: 3rd"; CHILLS (non-serious) with onset 29Oct2021 14:00, outcome "recovered" (30Oct2021), described as "shaking chills"; MYALGIA (non-serious) with onset 29Oct2021 14:00, outcome "recovered" (30Oct2021), described as "muscle aches"; HEADACHE (non-serious) with onset 29Oct2021 14:00, outcome "recovered" (30Oct2021), described as "headache"; FATIGUE (non-serious) with onset 29Oct2021 14:00, outcome "recovered" (30Oct2021), described as "fatigue"; PYREXIA (non-serious) with onset 29Oct2021 14:00, outcome "recovered" (30Oct2021), described as "fever to 103.4"; CHILLS (non-serious) with onset 29Oct2021 15:00, outcome "recovered" (2021), described as "Rigors". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of chills, myalgia, headache, fatigue, pyrexia. Therapeutic measures were not taken as a result of chills. No follow-up attempts are possible. No further information is expected.  Addition information : Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received Crestor, vitamin D, Advil PM, xyzal within 2 weeks of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the Fluzone vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No known allergies. Family medical history relevant to Adverse events, Relevant tests and specific relevant tests for thromboembolic events with thrombocytopenia was None. It was reported that within 90 minutes of receiving vaccine, started to develop shaking chills and muscle aches. Later developed headache, fatigue and fever to 103.4. All resolved within 24 hrs, treatment received for the adverse event with Advil. Patient received treatment for Fever to 103.4 with Tylenol, received treatment for Muscle aches with Advil, received treatment for Headache with Advil.